Lv4
720 积分 2025-02-10 加入
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
2天前
已完结
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers
2天前
已完结
IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
4天前
已完结
Heterodimeric IL-15 in Cancer Immunotherapy
4天前
已完结
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
5天前
已完结
Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry
9天前
已完结
Where Did the Linker-Payload Go? A Quantitative Investigation on the Destination of the Released Linker-Payload from an Antibody-Drug Conjugate with a Maleimide Linker in Plasma
9天前
已完结
A review of the novel tissue factor antibody–drug conjugate: Tisotumab vedotin
9天前
已完结
Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15
11天前
已完结
皖公网安备34019202002308
